CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $602,000 | +118.9% | 46,943 | +19.8% | 0.09% | +279.2% |
| Q2 2022 | $275,000 | -14.3% | 39,195 | +1.2% | 0.02% | -14.3% |
| Q1 2022 | $321,000 | -74.9% | 38,717 | -86.0% | 0.03% | -67.8% |
| Q2 2020 | $1,279,000 | +1.6% | 276,900 | -15.3% | 0.09% | -13.0% |
| Q1 2020 | $1,259,000 | -15.2% | 327,000 | -17.4% | 0.10% | +8.7% |
| Q4 2019 | $1,484,000 | +51.3% | 395,782 | +114.2% | 0.09% | +58.6% |
| Q3 2019 | $981,000 | – | 184,805 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |